Abstract
A physiologic pharmacodynamic model was developed to jointly characterize the effects of corticosteroid treatment on adrenal suppression and T-helper cell trafficking during single and multiple dosing in asthmatic patients. Methylprednisolone (MP), cortisol, and T-helper cell concentrations obtained from a previously published study during single day and 6 days of multiple dosing MP treatment were examined. The formation and disposition kinetics of MP were described with a compartmental model. The biorhythmic profile of basal cortisol secretion rate was analyzed using a recent Fourier approach based on circadian harmonics. A three-compartment loop model was proposed to represent three major T-helper cell pools: blood, extravascular site, and lymph nodes. T-helper cell synthesis and degradation rate constants were obtained from the literature. The suppressive effects of cortisol and MP on T-helper cell concentrations were described with a joint additive inhibition function altering the cell migration rate from lymph nodes to blood. The model adequately described both plasma cortisol profiles and T-helper cells in blood after single and multiple doses of MP. The potency of MP for suppression of cortisol secretion was estimated as IC50 = 0.8 ng/ml. The biorhythmic nature of the basal T-helper cells in blood was well described as under the influence of basal circadian cortisol concentrations with IC50 = 79 ng/ml. The model fitted potency of MP for suppression of T-helper cells was IC50 = 4.6 ng/ml. The observed rebound of T-helper cells in blood can also be described by the proposed model. The rhythm and suppression of plasma cortisol and T-helper cells before and during single and multiple dose MP treatment were adequately described by these extended indirect response models.
Similar content being viewed by others
REFERENCES
W. L. Ford and J. L. Gowans. The traffic of lymphocytes. Semin. Hematol. 6:67–83 (1969).
A. J. Young, J. B. Hay, and C. R. Mackay. Lymphocyte recirculation and life span in vivo. Curr. Topics Microbiol. Immunol. 184:161–173 (1993).
A. J. Young and J. B. Hay. Rapid turnover of the recirculating lymphocyte pool in vivo. Int. Immunol. 7:1607–1615 (1995).
A. K. Abbas, A. H. Lichtman, and J. S. Pober. Cellular and Molecular Immunology, W. B. Saunders, Philadfelphia, PA, 1994.
Y. Shoenfeld, Y. Gurewich, L. A. Gallant, and J. Pinkhas. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am. J. Med. 71:773–778 (1981).
T. Miyawaki, K. Taga, T. Nagaoki, H. Seki, Y. Suzuki, and N. Taniguchi. Circadian changes of T lymphocyte subsets in human peripheral blood. Clin. Exp. Immunol. 55:618–622 (1984).
H. B. Tavadia, K. A. Fleming, P. D. Hume, and H. W. Simpson. Circadian rhythmicity of human plasma cortisol and PHA-induced lymphocyte transformation. Clin. Exp. Immunol. 22:190–193 (1975).
B. Zweiman, P. C. Atkins, P. M. Bedard, S. L. Flaschen, and R. P. Lisak. Corticosteroid effects on circulating lymphocyte subset levels in normal humans. J. Clin. Immunol. 4:151–155 (1984).
T. E. Dunn, E. A. Ludwig, R. L. Slaughter, D. S. Camara, and W. J. Jusko. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin. Pharmacol. Ther. 49:536–549 (1991).
L. E. Fisher, E. A. Ludwig, and W. J. Jusko. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes. J. Pharmacokin. Biopharm. 20:319–331 (1992).
N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm. 21:457–478 (1993).
M. C. Braat, B. Oosterhuis, R. P. Koopmans, J. M. Meewis, and C. J. Van Boxtel. Kineticdynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone. J. Pharmacol. Exp. Ther. 262:509–515 (1992).
E. J. Ariëns and A. M. Simonis. A molecular basis for drug action. The interaction of one or more drugs with different receptors. J. Pharm. Pharmacol. 16:289–312 (1964).
M. A. Milad, E. A. Ludwig, S. Anne, E. Middleton, Jr., and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J. Pharmacokin. Biopharm. 22:469–480 (1994).
K. L. Slayter, E. A. Ludwig, K. H. Lew, E. Middleton, Jr., J. J. Ferry, and W. J. Jusko. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 59:312–321 (1996).
S. Rohatagi, A. Bye, C. Falcoz, A. E. Mackie, B. Meibohm, H. Mollmann, and H. Derendorf. Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate. J. Clin. Pharmacol. 36:938–941 (1996).
G. M. L. Meno-Tetang, R. A. Blum, K. E. Schwartz, and W. J. Jusko. Pharmacodynamic modeling of dehydroepiandrosterone (DHEA), DHEA-SO4 and cortisol suppression by prednisolone. Pharm. Res. 14:S609 (1997).
A. Chakraborty, R. A. Blum, D. L. Cutler, and W. J. Jusko. Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers. Clin. Pharmacol. Ther. 65:304–318 (1999).
W. Krzyzanski, A. Chakraborty, and W. J. Jusko. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol. Int. 17:77–93 (2000).
A. Chakraborty, W. Krzyzanski, and W. J. Jusko. Mathematical modeling of circadian cortisol concentrations using indirect response models: Comparison of several methods. J. Pharmacokin. Biopharm. 27:23–43 (1999).
E. O. Field, H. B. Sharpe, K. B. Dawson, V. Andersen, S. A. Killmann, and E. Weeke. Turnover rate of normal blood lymphocytes and exchangeable pool size in man, calculated from analysis of chromosomal aberrations sustained during extracorporeal irradiation of the blood. Blood 39:39–56 (1972).
F. Trepel. Number and distribution of lymphocytes in man. A critical analysis. Klin. Wochenschr. 52:511–515 (1974).
G. Reinecke and R. Pabst. Subsets of blood, spleen and recirculating lymphocytes in man. Clin. Exp. Immunol. 53:672–678 (1983).
M. Hellerstein, M. B. Hanley, D. Cesar, S. Siler, C. Papageorgopoulos, E. Wieder, D. Schmidt, R. Hoh, R. Neese, D. Macallan, S. Deeks, and J. M. McDune. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5:83–89 (1999).
A. N. Kong, E. A. Ludwig, R. L. Slaughter, P. M. DiStefano, J. DeMasi, E. Middleton, Jr., and W. J. Jusko. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin. Pharmacol. Ther. 46:616–628 (1989).
W. G. Reiss, R. L. Slaughter, E. A. Ludwidg, E. Middleton, Jr., and W. J. Jusko. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J. Allergy Clin. Immunol. 85:1058–1066 (1990).
D. Z. D'Argenio and A. Schumitzky. A program package for simulation and parameter estimation in pharmacokinetic systems. Comput. Prog. Biomed. 9:115–134 (1979).
J. J. Lima, J. Giller, J. J. Mackichan, and W. J. Jusko. Bioavailability of hydrocortisone retention enemas in normal subjects. Am. J. Gastroenterol. 73:232–237 (1980).
E. C. Butcher and L. J. Picker. Lymphocyte homing and homeostasis. Science 272:60–66 (1996).
H. B. Stamper and J. J. Woodruff. Lymphocyte homing into lymph nodes: In vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144:828–833 (1976).
W. M. Kieran, V. Blank, O. le Bail, and A. Israel. Lymphocyte homing. Res. Immunol. 140:399–450 (1989).
J. Westermann and R. Pabst. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest. 70:539–544 (1992).
A. Sharma, W. F. Ebling, and W. J. Jusko. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J. Pharm. Sci. 87:1577–1584 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chow, FS., Sharma, A. & Jusko, W.J. Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone. J Pharmacokinet Pharmacodyn 27, 559–575 (1999). https://doi.org/10.1023/A:1020974408657
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1020974408657